The access to medicine index: How ranking pharmaceutical companies encourages polycentric health governance

Akiko Kato and Yoshiko Naiki

Health Policy, 2021, vol. 125, issue 11, 1399-1405

Abstract: The field of access to medicines is becoming a complex governance system. Along with formal international organizations, non-state actors have created various new institutional arrangements, such as funds, initiatives, programs, and partnerships. This study focuses on the role and power of non-governmental organizations (NGOs) who have introduced a new dynamism regarding the problem of access to medicines, by analyzing the “Access to Medicine Index” (hereinafter, AtM Index) case.

Keywords: Access to medicines; Intellectual property; Pharmaceutical companies; Global health; Governance; NGOs (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851021002256
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:125:y:2021:i:11:p:1399-1405

DOI: 10.1016/j.healthpol.2021.09.002

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().